Very interesting.
The current cancer tests involve numerous blood tests or a biopsy in order to sequence a tumor. Among the cancers that the tests could detect is pancreatic, which to date lacks effective early screening capabilities.
“Down the road it might be possible to test for multiple cancers at the same time”, Professor Wong added.
Now scientists can only use blood tests to detect cancer if they have taken a biopsy and sequenced a tumour to discover which genetic signature to look for.
Good news and hope for Parkinson disease patients.
Erika Jucumin, a physician assistant at Neurology Associates in Ormond Beach, programs and monitors a deep brain stimulator for patients with Parkinson’s disease, dystonia and other neurological disorders.
As a result, Jacumin said she has seen many amazing turn-arounds in patients’ health. She spoke to The News-Journal about the device.
NAME: Erika Jacumin.
The article entitled “Yes Robots Will Steal Our Jobs, But Don’t Worry We’ll Get New Ones” published by Rawstory is a very Interesting Article; however, again, I see too many gaps that will need to be address before AI can eliminate 70% of today’s jobs. Below, are the top 5 gaps that I have seen so far with AI in taking over many government, business, and corporate positions.
1) Emotion/ Empathy Gap — AI has not been designed with the sophistication to provide personable care such as you see with caregivers, medical specialists, etc.
2) Demographic Gap — until we have a more broader mix of the population engaged in AI’s design & development; AI will not meet the needs for critical mass adoption; only a subset of the population will find will connection in serving most of their needs.
Lack of good Cyber Security across the net, will continue to be a key reason why AI in general will not deliver the return on new AI tech products and robots / devices. $3+ million in ranson may not be that large to mid size and large tech companies; however, it is everything to small businesses and small businesses and consumers is what keeps tech in business.
Hospital staff severely impeded in their day-to-day work.
Researchers say they’ve developed a 3-D bioprinter that can create artificial body parts with ready-made channels for getting nutrients and oxygen to the implanted cells. If the technology can be perfected, the device could solve one of the biggest obstacles to creating 3D-printed organs: how to nourish masses of manufactured tissue.
“It can fabricate stable, human-scale tissue of any shape,” Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine in North Carolina, said in a news release. “With further development, this technology could potentially be used to print living tissue and organ structures for surgical implantation.”
Atala and his colleagues describe their experiments with the bioprinter, known as the Integrated Tissue-Organ Printing System or ITOP, in a study published today by Nature Biotechnology.
Wow
WASHINGTON – A mysterious brain disorder can be confused with early Alzheimer’s disease although it isn’t robbing patients of their memories but of the words to talk about them.
It’s called primary progressive aphasia, and researchers said Sunday they’re finding better ways to diagnose the little-known syndrome. That will help people whose thoughts are lucid but who are verbally locked in to get the right kind of care.
“I’m using a speech device to talk to you,” Robert Voogt of Virginia Beach, Virginia, said by playing a recording from a phone-sized assistive device at a meeting of the American Association for the Advancement of Science. “I have trouble speaking, but I can understand you.”
Very nice.
NEW YORK: Enriching T cells — a type of white blood cell — to attack certain cancerous diseases may prove beneficial to an increasing number of children during immunotherapy, says a study.
Younger T cells, classified as either naive T cells (newly minted cells) or stem central memory T cells (self-renewing, highly proliferative cells) were the most effective in immunotherapy, the study showed.
“Our main finding is that younger T cells are critically important in T cell immunotherapy,” said David M. Barrett, paediatric oncologist at The Children’s Hospital of Philadelphia (CHOP), University of Pennsylvania, US.
WIKIPEDIA, AYACOP Boosting levels of ghrelin, a hormone involved in hunger, keeps aging-related declines at bay in mice, according to a study published yesterday (February 2) in Molecular Psychiatry.
The authors gave mice a traditional Japanese medicine called rikkunshito or an extract from rikkunshito to stimulate hormone production. In three different mouse lines—two with shortened lifespans and another with a normal lifespan—the treatment resulted in the animals living longer.
“These findings suggest that the elevated endogenous ghrelin signaling has an important role in preventing aging-related premature death,” Akio Inui of Kagoshima University Graduate School of Medical and Dental Sciences and colleagues wrote in their report.
A group of scientists are calling on the WHO to classify aging as a disease, asserting that we need to create a better classification for what happens to our bodies as we get older.
A new controversy is brewing, as one group of scientists is recommending that aging be considered a disease.
Scientists from Insilico Medicine are highlighting the need to create a more granular and applied classification for what happens to our bodies when we age. Their work is outlined in a recent paper published in Frontiers in Genetics. The classification that they argue for is based on the World Health Organization’s (WHO) International Statistical Classification of Diseases and Related Health Problems (ICD-11), which is expected to be finalized in 2018.
Cotton Candy’s new inspiration.
Scientists are now able to spin a three-dimensional slab of gelatin that contains a microvascular network, something very like our capillaries, using a cotton candy-esque machine.
What do cotton candy and artificial organs have in common? More than you might think.
Leon Bellan, assistant professor of mechanical engineering at Vanderbilt University, is using a cotton candy machine to spin out networks of tiny threads comparable in size, density, and complexity to the patterns formed by capillaries.
